ARMANDO CORONA JOINS MYERS BIGEL

Myers Bigel is pleased to announce Armando Corona has joined the firm’s award-winning legal team.

Armando Corona received his B.S. in Chemistry from the University of North Carolina at Pembroke. Here, he was part of various research projects in the chemistry department finding more effective methods to produce biodiesel from used cooking oil. After completing his B.S. Degree, Armando spent one year at The University of North Carolina at Chapel Hill testing anti-Notch signaling antibodies to target aggressive kidney cancer. Armando received his Ph.D. in Pharmacology and Cancer Biology from Duke University. His doctoral research focused on identifying regulators of the TGF-β signaling pathway in metastatic breast cancer cells.

He has a diverse scientific research background including molecular biology methods such as cell culture, genetically engineered mouse modeling, cellular cloning, proteomics, next generation sequencing, testing cancer cell metastasis potential and cellular signaling.

Armando recently passed the U.S. Patent and Trademark Office patent bar exam and will soon receive his official registration.

Armando joins a team of attorneys and patent agents emphasizing patent procurement in practice areas including electronics/computer, mechanical, trademark, chemical and biotechnology. The firm’s experience with domestic and international patents is vast, having successfully filed in practically every country in the world, drafting quality patents that cover the full scope of an invention and stand up to courtroom challenges.